HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose oral contraceptives: health consequences of discontinuation.

Abstract
Presently, the lowest effective estrogen dose available as a combination oral contraceptive (OC) in the United States is 20 microg of ethinyl estradiol (EE) with different progestins. Twenty micrograms of EE coupled with levonorgestrel results in fewer side effects and cycle control comparable with higher-dose pills. Differences between therapeutically equivalent and brand-name, low-dose oral contraceptives, with respect to the bioavailability of hormones, may interfere with contraceptive efficacy and increase breakthrough bleeding. One of the most common reasons why women discontinue OCs is increased breakthrough bleeding. Because after OC discontinuation most women switch to a less-effective method, or no method, of contraception, an increase in breakthrough bleeding could ultimately result in an increase in unintended pregnancy. Thus, substituting a therapeutically equivalent for a brand-name low-dose oral contraceptive may have significant clinical and economic effects on individual and public health.
AuthorsR Ansbacher
JournalContraception (Contraception) Vol. 62 Issue 6 Pg. 285-8 (Dec 2000) ISSN: 0010-7824 [Print] United States
PMID11239614 (Publication Type: Journal Article, Review)
Chemical References
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Drugs, Generic
  • Estradiol Congeners
  • Progesterone Congeners
  • Ethinyl Estradiol
Topics
  • Adolescent
  • Adult
  • Contraceptives, Oral, Combined (administration & dosage, adverse effects, pharmacokinetics)
  • Contraceptives, Oral, Hormonal (administration & dosage, adverse effects, pharmacokinetics)
  • Dose-Response Relationship, Drug
  • Drugs, Generic (administration & dosage, adverse effects)
  • Estradiol Congeners (administration & dosage)
  • Ethinyl Estradiol (administration & dosage)
  • Female
  • Humans
  • Pregnancy
  • Pregnancy, Unwanted
  • Progesterone Congeners (administration & dosage, adverse effects)
  • Therapeutic Equivalency
  • Uterine Hemorrhage (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: